BMN-290

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameBMN-290
Drug Alias NameFXN stimulators (Scripps)HDAC inhibitor 4b (RepliGen)frataxin gene stimulators (Repligen)FXN stimulators (Repligen)frataxin gene stimulators (Scripps) +[14] 
ClassificationSmall molecules
Mechanisms of ActionHistone deacetylase 1 inhibitorsFrataxin Gene transferenceHistone deacetylase 3 inhibitors +[5] 
TargetsHistone deacetylase 1Histone deacetylase 3Frataxin, mitochondrial +[4] 
Therapy Area/IndicationsFriedreich AtaxiaNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Scripps Research Institute Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiomarin Pharmaceutical IncRepligen CorpThe Scripps Research Institute Inc
Active IndicationsN/A
Inactive IndicationsFriedreich AtaxiaNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A